% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • samur999 samur999 Jan 14, 2012 11:53 AM Flag

    Amiket story

    Simply look in their balance sheet and the course of the share price of the last years. That tells the story of the „progress" of these management guys, better than stupid comments.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • NCI have performed a phase IIb trial having 461 participants using Amiket.

      The results seems to be excellent? P-value 0,001.

      A third part evaluation of the economic outcome from the future Amiket market - in the US alone - seems more than interesting? 400 MUSD per annum. Epicept will seek approval in the EU as well.

      We are now waiting for the minutes from the end-of -phase 2-meeting that the representaives have named a "succes" as for the design of the phase III that will start late Q2. After that Epicept will negotiate a SPA for Amikets phase III trial.

0.375-0.023(-5.78%)May 3 4:00 PMEDT